» Articles » PMID: 35122176

First Live Birth After Fertility Preservation Using Vitrification of Oocytes in a Woman with Mosaic Turner Syndrome

Overview
Publisher Springer
Date 2022 Feb 5
PMID 35122176
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To report the case of a young woman diagnosed with Turner syndrome (TS) who achieved a live birth using her own oocytes that had been vitrified for fertility preservation.

Methods: A 25-year-old woman with mosaic (45,X/46,XX) TS was referred for fertility preservation (FP) counseling. Serum anti-Müllerian hormone (AMH) level was normal (6.4 µg/L). In view of the unpredictable rate of follicle loss in TS individuals, she requested FP and underwent two cycles of ovarian stimulation (OS) for oocyte cryopreservation (OoC) using a GnRH antagonist protocol and recombinant follicle stimulating hormone (rFSH), 200-250 IU daily for 8 resp. 12 days.

Results: In total, 29 metaphase II oocytes (MII) were vitrified after OS. After conceiving spontaneously and achieving a live birth, she returned to the clinic five years after OoC with a desire for pregnancy using in vitro fertilization (IVF) of her cryopreserved oocytes and preimplantation genetic testing (PGT-A). All 29 MII oocytes were thawed; 23 oocytes survived (79.3%) and were inseminated with partner sperm using intracytoplasmic sperm injection (ICSI). Thirteen oocytes were fertilized resulting in three good quality blastocysts which were vitrified after trophectoderm biopsy for PGT-A using array-CGH. Two blastocysts were found to be euploid. One was thawed and transferred to the uterus using a HRT priming protocol. An uneventful pregnancy occurred. The patient delivered a healthy baby girl weighing 3490 g at 40 weeks of gestation.

Conclusions: We report the first live birth achieved using cryopreserved oocytes in a woman diagnosed with mosaic TS. Cryopreservation of oocytes after ovarian stimulation is a realistic option for FP in selected post menarche individuals with mosaic TS. Whether PGT-A may reduce the risk of pregnancy loss in TS has to be confirmed by further studies.

Citing Articles

A rare viable delivery of a 45,X/46,XY mosaicism female with complete gonadal dysgenesis after receiving oocyte donation and overcoming multiple pregnancy complications.

Luo Y, Liao X, Wen J, Wu W, Tang G, Zhu H J Assist Reprod Genet. 2025; .

PMID: 39903408 DOI: 10.1007/s10815-025-03394-9.


Clinical practice guidelines for the care of girls and women with Turner syndrome.

Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.

PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.


Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.

van der Coelen S, van der Velden J, Nadesapillai S, Braat D, Peek R, Fleischer K Hum Reprod Update. 2024; 30(4):383-409.

PMID: 38452347 PMC: 11215162. DOI: 10.1093/humupd/dmae005.


Oocyte cryopreservation in mosaic Turner syndrome with polycystic ovaries.

Sienko A, Prakash A, MacDougall J F S Rep. 2024; 4(4):380-383.

PMID: 38204943 PMC: 10774874. DOI: 10.1016/j.xfre.2023.10.001.


Reproductive health in Turner's syndrome: from puberty to pregnancy.

Porcu E, Cipriani L, Damiano G Front Endocrinol (Lausanne). 2023; 14:1269009.

PMID: 38116311 PMC: 10728473. DOI: 10.3389/fendo.2023.1269009.


References
1.
Mamsen L, Charkiewicz K, Anderson R, Telfer E, Mclaughlin M, Kelsey T . Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation. Fertil Steril. 2019; 111(6):1217-1225.e3. DOI: 10.1016/j.fertnstert.2019.02.003. View

2.
Nadesapillai S, van der Velden J, Braat D, Peek R, Fleischer K . The challenge of defining predictive parameters for fertility preservation counseling in young females with Turner syndrome. Acta Obstet Gynecol Scand. 2021; 100(6):1155-1156. DOI: 10.1111/aogs.14094. View

3.
Jacobs P, DAlton P, James R, Mosse K, Power M, Robinson D . Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet. 1998; 61(Pt 6):471-83. DOI: 10.1046/j.1469-1809.1997.6160471.x. View

4.
Gravholt C, Viuff M, Brun S, Stochholm K, Andersen N . Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019; 15(10):601-614. DOI: 10.1038/s41574-019-0224-4. View

5.
Peek R, Schleedoorn M, Smeets D, van de Zande G, Groenman F, Braat D . Ovarian follicles of young patients with Turner's syndrome contain normal oocytes but monosomic 45,X granulosa cells. Hum Reprod. 2019; 34(9):1686-1696. PMC: 6736193. DOI: 10.1093/humrep/dez135. View